Crossmark

Daily Oral Pre-exposure Prophylaxis (PrEP) Continuation Among Women from Durban, South Africa, Who Initiated PrEP as Standard of Care for HIV Prevention in a Clinical Trial

Crossref DOI link: https://doi.org/10.1007/s10461-022-03592-x

Published Online: 2022-02-05

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Beesham, Ivana https://orcid.org/0000-0003-4889-8123
Joseph Davey, Dvora L.

Beksinska, Mags

Bosman, Shannon

Smit, Jenni

Mansoor, Leila E.
Funding

Funding for this research was provided by:

bill and melinda gates foundation (OPP1032115)

united states agency for international development (AID-OAA-A-15–00045)

swedish international development cooperation agency (2017/762965–0)

south african medical research council

united nations population fund

match research unit

government of south africa
License Information

Text and Data Mining valid from 2022-02-05

Version of Record valid from 2022-02-05
More Information

Article History

Accepted: 15 January 2022

First Online: 5 February 2022

Declarations

:

: The authors have none to declare.

: The ECHO trial was approved by University of Witwatersrand Human Research Ethics Committee (Wits HREC) and the FHI360 ethics review board. This ancillary study was approved by Wits HREC (Reference 141112).

: Informed consent was obtained from women to participate in the ECHO trial, and additional informed consent was obtained to participate in this ancillary study.

: Not applicable.

Document is current

Any future updates will be listed below